Internal Medicine · Phoenixville, PA
NPI
1467491050
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
826 Main St, Suite 100
Phoenixville, PA, 19460
Phone (610) 933-8484
Groups this clinician bills Medicare through
Medicare paid, 2024
$72K
1,772 services
Medicare patients, 2024
536
Average age 74
Drug cost, 2024
$838K
11,422 prescriptions
Company payments, 2024
$112
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Brown was code 99214 (office e&m - established), 448 times for 348 patients. In total Mark Brown billed 1,772 services in 36 codes, and Medicare paid $72K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-02-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 448 | 348 | $47.38 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 447 | 354 | $10.81 | $4,834 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 397 | 397 | $55.27 | $22K |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 43 | 38 | $58.47 | $2,514 |
| G0008 Administration of influenza virus vaccine | Office | 42 | 42 | $33.29 | $1,398 |
| 90662 Vaccine Product | Office | 40 | 40 | $80.83 | $3,233 |
| 96372 Injection Administration | Office | 40 | 12 | $9.65 | $386 |
| 99213 Office E&M - Established | Office | 33 | 32 | $21.35 | $704 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 28 | 11 | $0.83 | $23.11 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 24 | 24 | $89.44 | $2,147 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 21 | 21 | $162.56 | $3,414 |
| 93000 Electrocardiogram | Office | 19 | 19 | $10.49 | $199 |
| 99215 Office E&M - Established | Office | 17 | 17 | $79.07 | $1,344 |
| G0403 Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 15 | 15 | $5.47 | $82.06 |
| 90677 Vaccine Product | Office | 12 | 12 | $289.78 | $3,477 |
By year: 2022 $68K for 1,263 services; 2023 $64K for 1,351 services; 2024 $72K for 1,772 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Brown prescribed most often to Medicare patients was Atorvastatin Calcium, with 966 prescriptions and refills. In total Mark Brown wrote 11,422 Medicare prescriptions that cost $838K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 966 | 2,527 | 252 | $12K |
| Lisinopril Generic | 583 | 1,609 | 164 | $4,014 |
| Levothyroxine Sodium Generic | 537 | 1,394 | 139 | $6,395 |
| Amlodipine Besylate Generic | 525 | 1,329 | 138 | $2,990 |
| Rosuvastatin Calcium Generic | 376 | 1,071 | 113 | $6,372 |
| Bisoprolol-Hydrochlorothiazide Bisoprolol/Hydrochlorothiazide | 342 | 826 | 83 | $8,819 |
| Losartan Potassium Generic | 322 | 925 | 92 | $3,283 |
| Pantoprazole Sodium Generic | 301 | 780 | 91 | $4,457 |
| Simvastatin Generic | 276 | 783 | 79 | $2,776 |
| Metoprolol Succinate Generic | 234 | 637 | 68 | $3,495 |
| Metformin Hcl Generic | 232 | 646 | 66 | $2,334 |
| Escitalopram Oxalate Generic | 230 | 420 | 58 | $2,253 |
| Omeprazole Generic | 226 | 576 | 55 | $1,832 |
| Hydrochlorothiazide Generic | 213 | 492 | 54 | $899 |
| Lorazepam Generic | 183 | 183 | 41 | $810 |
Brand drugs: 965 claims; generic drugs: 10,416 claims; opioid claims: 218.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Mark Brown $112 ($112 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $112.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $112 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.